763 research outputs found

    Radioecology at ANSTO 2016 and into the future

    Get PDF
    No abstract available

    Screening assessment of dose rates to wildlife related to the Nuclear Medicine Mo99 Facility

    Get PDF
    ANSTO has performed a screening assessment on potential dose rates to environmental receptors (wildlife) associated with the planned ANSTO Nuclear Medicine (ANM) Mo99 Facility. The ANM facility will be located on the 50 hectare ANSTO Lucas Heights site, which is surrounded by a 1.6 km radius buffer zone owned by the Commonwealth or its Agencies. The buffer zone is used by humans for recreational purposes and is home to a range of plant and animal wildlife. During its routine operations in producing medical isotopes and performing research, ANSTO releases small amounts of radionuclides through stack emissions and, after testing, through liquid discharges to the public sewer system. The purpose of this assessment is to use a standard screening approach to determine if potential dose rates to local wildlife from future releases, including the ANM Mo99 Facility, are below international benchmarks. The assessment used methods from international best practice as laid out by the ARPANSA Guide: Radiation Protection of the Environment, which is consistent with current approaches set forth by the International Commission on Radiological Protection (ICRP) and the International Atomic Energy Agency (IAEA). The screening evaluations considered exposure to a range of terrestrial organisms in the buffer zone from stack emissions via the air pathway, and, to a range of marine organisms near the ocean outlet at Potter Point, New South Wales via the liquid effluent pathway. Dose assessments were performed using the ERICA tool with radioactivity concentrations for air and water determined from data collected during routine monitoring of stack emissions and effluent releases at ANSTO. Concentration values along air and water pathways were overestimated, consistent with an approach of using conservative assumptions in this screening assessment. In summary, despite using overestimates for radioactivity concentrations associated with ANSTO’s emissions, results indicate potential risk quotients that are below standard benchmarks for all organisms and all pathways considered. Dose rates to organisms were determined to be below the lowest benchmark for potential harmful effects (10 μGy hr-1). These results are consistent with previous studies in determining no significant impacts from ANSTO effluents. Therefore, potential radioactivity releases from the ANM Facility are unlikely to impact local wildlife. Although projected dose rates are low, the release of low levels of radionuclides in air and water discharges indicates the need for ongoing monitoring and periodic re-evaluation

    Accumulation of plutonium in mammalian wildlife tissues: comparison of recent data with the ICRP distribution models

    Get PDF
    We examined the distribution of plutonium (Pu) in the tissues of mammalian wildlife to address the paucity of such data under environmental exposure conditions. Pu activity concentrations were measured in Macropus rufus (red kangaroo), Oryctolagus cuniculus (European rabbit), and Pseudomys hermannsburgensis (sandy inland mouse)inhabiting the relatively undisturbed, semi-arid conditions at the former Taranaki weapons test site at Maralinga, Australia. Of the absorbed Pu (distributed via circulatory and lymph systems) accumulation was foremost in bone (83% ±10% SD), followed by muscle (9% ±10%), liver (7% ±7%), kidneys (0.5% ±0.3%), and heart (0.4% ±0.4%). The bone values are higher than those reported in ICRP 19 and 48 (45-50% bone), while the liver values are lower than ICRP values (30-45% liver). The ICRP values were based on data dominated by relatively soluble forms of Pu, including prepared solutions and single-atom ions produced by decay following the volatilisation of uranium during nuclear detonation (fallout Pu, ICRP 1986). In contrast, the Maralinga data relates to low-soluble forms of Pu used in tests designed to simulate accidental release and dispersal. We measured Pu in lung, GI-tract and the skin and fur as distinct from the absorbed Pu in bone, liver, muscle, and kidneys. Compared with the mean absorbed activity concentrations, the results for lung tissues were higher by up to one order of magnitude, and those in the GI tract contents and the washed skin/fur were higher by more than two orders of magnitude. These elevated levels are consistent with the presence of low-soluble Pu, including particulate forms, which pass through, or adhere upon, certain organs, but are not readily absorbed into the bloodstream. This more transitory Pu can provide dose to the lung and GI tract organs, as well as provide potential transfer of contamination when consumed in predator-prey food chains, or during human foodstuff consumption. For example, activity concentrations in O. cuniculus edible samples prepared according to traditional aboriginal methods were more than two orders of magnitude higher than in muscle alone. The increase was due to inclusion of GI tract components and contents in the traditional method. Our results provide new insights into the sequestration of Pu in mammalian tissues under environmental exposure conditions. These results contrast with those related to the specific forms of Pu and exposure conditions upon which the ICRP models were based. However, they provide data relevant to the assessment of key environmental legacy waste sites, and of potential release scenarios for the low-soluble oxide forms in the growing worldwide inventory of Pu associated with power production

    Dose modelling comparison for terrestrial biota: IAEA EMRAS II Biota Working Group's Little Forest Burial Ground scenario

    Get PDF
    Radiological doses to terrestrial biota have been examined in a model inter-comparison study that emphasised the identification of factors causing variability in dose estimation. Radiological dose rates were modelled for ten species representing a diverse range of terrestrial plant and animals with varying behavioural and physical attributes. Dose to these organisms may occur from a range of gamma (Co-60, Cs-137), beta (Sr-90) and alpha (Th-232, U-234 and U-238, Pu-238, Pu-239/240 and Am-241) emitting radionuclides. Whilst the study was based on a specific site - the Little Forest Burial Ground, New South Wales, and Australia - it was intended to be representative of conditions at sites throughout the world where low levels of radionuclides exist in soil due to waste disposal or similar activities

    Plutonium transfer to wildlife at legacy sites

    Get PDF
    When internalized within an organism’s body, plutonium (Pu) can be important in dose calculation due to its relatively high-energy alpha emissions (~5-6 MeV). In this paper we quantify transfer of Pu to a range of wildlife types at legacy nuclear weapons sites and evaluate the importance of body tissue Pu distribution in the transfer of Pu through the food chain. The paper presents new data from Maralinga, Australia, as well as past data from terrestrial and marine settings of the US nuclear research program

    Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes

    Get PDF
    Background: Patients with multiple sclerosis (MS) have a decreased frequency of CD8(+) T cells reactive to their own Epstein-Barr virus (EBV) infected B cells. We have proposed that this might predispose to the development of MS by allowing EBV-infected autoreactive B cells to accumulate in the central nervous system. The decreased CD8(+) T cell response to EBV results from a general CD8(+) T cell deficiency and also a decreased proportion of EBV-specific T cells within the total CD8(+) T cell population. Because decreased HLA class I expression on monocytes and B cells has been reported in MS and could influence the generation and effector function of EBV-specific CD8(+) T cells, the present study was undertaken to measure the expression of HLA molecules on B cells and monocytes in patients with MS

    Integrating isotopes and documentary evidence : dietary patterns in a late medieval and early modern mining community, Sweden

    Get PDF
    We would like to thank the Archaeological Research Laboratory, Stockholm University, Sweden and the Tandem Laboratory (Ångström Laboratory), Uppsala University, Sweden, for undertaking the analyses of stable nitrogen and carbon isotopes in both human and animal collagen samples. Also, thanks to Elin Ahlin Sundman for providing the δ13C and δ15N values for animal references from Västerås. This research (Bäckström’s PhD employment at Lund University, Sweden) was supported by the Berit Wallenberg Foundation (BWS 2010.0176) and Jakob and Johan Söderberg’s foundation. The ‘Sala project’ (excavations and analyses) has been funded by Riksens Clenodium, Jernkontoret, Birgit and Gad Rausing’s Foundation, SAU’s Research Foundation, the Royal Physiographic Society of Lund, Berit Wallenbergs Foundation, Åke Wibergs Foundation, Lars Hiertas Memory, Helge Ax:son Johnson’s Foundation and The Royal Swedish Academy of Sciences.Peer reviewedPublisher PD

    Influence of wiring cost on the large-scale architecture of human cortical connectivity

    Get PDF
    In the past two decades some fundamental properties of cortical connectivity have been discovered: small-world structure, pronounced hierarchical and modular organisation, and strong core and rich-club structures. A common assumption when interpreting results of this kind is that the observed structural properties are present to enable the brain's function. However, the brain is also embedded into the limited space of the skull and its wiring has associated developmental and metabolic costs. These basic physical and economic aspects place separate, often conflicting, constraints on the brain's connectivity, which must be characterized in order to understand the true relationship between brain structure and function. To address this challenge, here we ask which, and to what extent, aspects of the structural organisation of the brain are conserved if we preserve specific spatial and topological properties of the brain but otherwise randomise its connectivity. We perform a comparative analysis of a connectivity map of the cortical connectome both on high- and low-resolutions utilising three different types of surrogate networks: spatially unconstrained (‘random’), connection length preserving (‘spatial’), and connection length optimised (‘reduced’) surrogates. We find that unconstrained randomisation markedly diminishes all investigated architectural properties of cortical connectivity. By contrast, spatial and reduced surrogates largely preserve most properties and, interestingly, often more so in the reduced surrogates. Specifically, our results suggest that the cortical network is less tightly integrated than its spatial constraints would allow, but more strongly segregated than its spatial constraints would necessitate. We additionally find that hierarchical organisation and rich-club structure of the cortical connectivity are largely preserved in spatial and reduced surrogates and hence may be partially attributable to cortical wiring constraints. In contrast, the high modularity and strong s-core of the high-resolution cortical network are significantly stronger than in the surrogates, underlining their potential functional relevance in the brain

    Cancer after cholecystectomy: record-linkage cohort study

    Get PDF
    We investigated whether cholecystectomy is associated with subsequent cancer and, if so, whether the association is likely to be causal, by undertaking a retrospective cohort study using linked medical statistics, comprising a cholecystectomy group (n=39 254) and a reference cohort admitted for a range of other medical and surgical conditions (n=334 813). We found a short-term significant elevation of rates of cancers of the colon, pancreas, liver, and stomach after cholecystectomy, but no long-term elevation. Excluding colon cancers within 2 years of admission to hospital, the rate ratio for colon cancer after cholecystecomy, compared with the reference cohort, was 1.01 (95% confidence interval 0.90–1.12) and after 10 years or more follow-up it was 0.94 (0.79–1.10). It is highly improbable that the short-term associations between cholecystectomy and gastrointestinal cancers are causal, and we conclude that cholecystectomy does not cause cancer
    corecore